Latest Beta amyloid Stories
Weill Cornell Medical College neurologist Dr. Norman Relkin reported new findings today from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer's disease at the Alzheimer's Association International Conference (AAIC) in Boston, Mass.
Researchers say they have been working with a tiny yet promising new drug-like molecule that could lead to a preventative treatment for Alzheimer’s disease.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.